Publikace
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study2006 | Fakulta tělesné výchovy a sportu
- Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women2003 | Fakulta tělesné výchovy a sportu
- The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status2003 | Fakulta tělesné výchovy a sportu
- Geographic and other determinants of BMD change in European men and women at the hip and spine. A population-based study from the Network in Europe for Male Osteo-porosis (NEMO)2007 | Fakulta tělesné výchovy a sportu
- Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis2007 | Fakulta tělesné výchovy a sportu
- No associations between genetic polymorphisms of TGF-beta, PAI-1, and COL1A1, and bone mineral density in caucasian females2006 | Fakulta tělesné výchovy a sportu
- The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis2006 | Fakulta tělesné výchovy a sportu
- Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study2006 | Fakulta tělesné výchovy a sportu
- The risk of Colle's fracture is associated with the collagen I Alpha1 Sp1 polymorphism and ultrasound transmission velocity in the calcaneus only in heavier postmenopausal women2005 | Fakulta tělesné výchovy a sportu
- Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study2005 | Fakulta tělesné výchovy a sportu
Loading network view...